CMG Pharmaceutical (058820.KQ) Earnings Analysis
CMG Pharmaceutical (058820.KQ) has no confirmed upcoming earnings date. Trailing P/E -15.59.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 058820.KQ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 058820.KQ. This page updates as the calendar is published.
058820.KQ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2024-12-31 | -20.50202 KRW | n/a | n/a | n/a |
058820.KQ valuation and analyst view
| Trailing P/E | -15.59 |
|---|---|
| Trailing EPS | -50.39666 KRW |
| Price / book | 0.57 |
| Dividend yield | 0.00% |
| Market cap | 116.06B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is CMG Pharmaceutical (058820.KQ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 058820.KQ. This page updates as the calendar is published.
Did 058820.KQ beat earnings last quarter?
Consensus estimate data was not available for 058820.KQ's 2024-12-31 report.
What is 058820.KQ's current P/E ratio and EPS?
058820.KQ trades at a trailing P/E of -15.59 on trailing EPS of -50.396658628719074 KRW.
What do analysts rate 058820.KQ?
058820.KQ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.